2024 Q3 Form 10-Q Financial Statement
#000141168524000037 Filed on August 13, 2024
Income Statement
| Concept | 2024 Q3 | 2024 Q2 | 2024 Q1 |
|---|---|---|---|
| Revenue | $200.0K | $100.0K | $197.3K |
| YoY Change | -27.98% | -43.69% | 12.1% |
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $4.195M | $4.567M | $4.120M |
| YoY Change | 30.69% | 53.35% | 33.87% |
| % of Gross Profit | |||
| Research & Development | $10.22M | $7.648M | $7.437M |
| YoY Change | 165.28% | 82.22% | -20.35% |
| % of Gross Profit | |||
| Depreciation & Amortization | $37.00K | $34.00K | $32.50K |
| YoY Change | 23.33% | 7.94% | -2.4% |
| % of Gross Profit | |||
| Operating Expenses | $14.41M | $12.22M | $11.56M |
| YoY Change | 104.17% | 70.23% | -6.92% |
| Operating Profit | -$14.23M | -$12.13M | |
| YoY Change | 109.83% | 73.35% | |
| Interest Expense | $1.273M | $1.398M | $1.527M |
| YoY Change | 570.0% | 1338.27% | 12116.8% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $312.0K | ||
| YoY Change | |||
| Pretax Income | -$12.95M | -$10.73M | -$9.520M |
| YoY Change | 96.64% | 55.54% | -22.13% |
| Income Tax | $7.000K | $0.00 | $1.500K |
| % Of Pretax Income | |||
| Net Earnings | -$12.96M | -$10.73M | -$9.521M |
| YoY Change | 96.75% | 55.48% | -22.13% |
| Net Earnings / Revenue | -6480.5% | -10733.0% | -4825.85% |
| Basic Earnings Per Share | -$0.42 | -$0.35 | |
| Diluted Earnings Per Share | -$0.42 | -$0.35 | -$0.31 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 27.06M shares | 27.03M shares | 27.03M |
| Diluted Shares Outstanding | 30.63M shares | 30.60M shares |
Balance Sheet
| Concept | 2024 Q3 | 2024 Q2 | 2024 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $97.58M | $108.4M | $119.2M |
| YoY Change | 159.52% | 1026.18% | 616.25% |
| Cash & Equivalents | $84.25M | $102.9M | $119.2M |
| Short-Term Investments | $13.33M | $5.446M | $0.00 |
| Other Short-Term Assets | $2.370M | $2.474M | $1.506M |
| YoY Change | 58.0% | 67.56% | 153.07% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $99.95M | $110.8M | $120.7M |
| YoY Change | 155.78% | 857.25% | 589.26% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $467.0K | $489.0K | $435.0K |
| YoY Change | 5.11% | 2.77% | -14.25% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $498.0K | $518.0K | $726.0K |
| YoY Change | -17.0% | -37.13% | -10.83% |
| Total Long-Term Assets | $2.548M | $2.710M | $2.981M |
| YoY Change | -18.32% | -21.53% | -16.77% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $99.95M | $110.8M | $120.7M |
| Total Long-Term Assets | $2.548M | $2.710M | $2.981M |
| Total Assets | $102.5M | $113.5M | $123.7M |
| YoY Change | 142.91% | 655.36% | 486.33% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $715.0K | $1.209M | $1.547M |
| YoY Change | -45.21% | -25.52% | -37.45% |
| Accrued Expenses | $3.815M | $2.164M | $2.235M |
| YoY Change | 1203.83% | 409.54% | 183.85% |
| Deferred Revenue | $2.468M | $2.296M | $791.0K |
| YoY Change | 211.22% | 221.43% | 10.74% |
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $7.523M | $6.236M | $5.123M |
| YoY Change | 158.57% | 54.01% | 12.16% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| Other Long-Term Liabilities | $1.999M | $2.509M | $4.244M |
| YoY Change | -44.47% | -39.21% | -4.29% |
| Total Long-Term Liabilities | $1.999M | $2.509M | $4.244M |
| YoY Change | -45.1% | -39.31% | -4.45% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $7.523M | $6.236M | $5.123M |
| Total Long-Term Liabilities | $1.999M | $2.509M | $4.244M |
| Total Liabilities | $9.522M | $8.745M | $9.367M |
| YoY Change | 45.36% | 6.86% | 3.97% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$379.9M | -$366.9M | -$356.2M |
| YoY Change | 11.62% | 9.92% | 8.96% |
| Common Stock | $27.00K | $27.00K | $27.00K |
| YoY Change | 125.0% | 241.77% | 269.86% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $92.97M | $104.8M | $114.3M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $102.5M | $113.5M | $123.7M |
| YoY Change | 142.91% | 655.36% | 486.33% |
Cashflow Statement
| Concept | 2024 Q3 | 2024 Q2 | 2024 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$12.96M | -$10.73M | -$9.521M |
| YoY Change | 96.75% | 55.48% | -22.13% |
| Depreciation, Depletion And Amortization | $37.00K | $34.00K | $32.50K |
| YoY Change | 23.33% | 7.94% | -2.4% |
| Cash From Operating Activities | -$10.89M | -$10.87M | -$7.197M |
| YoY Change | 75.86% | 37.74% | -3.69% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $61.00K | $42.00K | $28.70K |
| YoY Change | |||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$7.725M | -$5.425M | $0.00 |
| YoY Change | -100.0% | ||
| Cash From Investing Activities | -$7.786M | -$5.467M | -$28.70K |
| YoY Change | -94.57% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | $88.00K | -167.8K |
| YoY Change | -100.0% | -89.95% | -57.91% |
| NET CHANGE | |||
| Cash From Operating Activities | -10.89M | -$10.87M | -7.197M |
| Cash From Investing Activities | -7.786M | -$5.467M | -28.70K |
| Cash From Financing Activities | 0.000 | $88.00K | -167.8K |
| Net Change In Cash | -18.67M | -$16.25M | -7.394M |
| YoY Change | -166.73% | 131.61% | -11.98% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$10.89M | -$10.87M | -$7.197M |
| Capital Expenditures | $61.00K | $42.00K | $28.70K |
| Free Cash Flow | -$10.95M | -$10.91M | -$7.226M |
| YoY Change | 76.85% | 38.27% | -3.3% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2024Q2 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
84000 | usd |
| CY2023Q2 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
177000 | usd |
| CY2024Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7648000 | usd |
| CY2023Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4197000 | usd |
| CY2024Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4567000 | usd |
| CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2978000 | usd |
| CY2024Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
12215000 | usd |
| CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
7175000 | usd |
| CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12131000 | usd |
| CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6998000 | usd |
| CY2024Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
1398000 | usd |
| CY2023Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
98000 | usd |
| CY2024Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-10733000 | usd |
| CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-6900000 | usd |
| CY2024Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3000 | usd |
| CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10733000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6903000 | usd |
| CY2024Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
2000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
0 | usd |
| CY2024Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-10731000 | usd |
| CY2023Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-6903000 | usd |
| CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.35 | |
| CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.35 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.94 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.94 | |
| CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
30603435 | shares |
| CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30603435 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7337005 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7337005 | shares |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12080000 | usd |
| CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
569000 | usd |
| CY2023Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
4000 | usd |
| CY2023Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1099000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6903000 | usd |
| CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6849000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
114286000 | usd |
| CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1160000 | usd |
| CY2024Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
88000 | usd |
| CY2024Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
|
2000 | usd |
| CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10733000 | usd |
| CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
104803000 | usd |
| CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10733000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6903000 | usd |
| CY2024Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
34000 | usd |
| CY2023Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
32000 | usd |
| CY2024Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1160000 | usd |
| CY2023Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
569000 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
117000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
107000 | usd |
| CY2024Q2 | vtgn |
Accretion On Marketable Securities
AccretionOnMarketableSecurities
|
-19000 | usd |
| CY2023Q2 | vtgn |
Accretion On Marketable Securities
AccretionOnMarketableSecurities
|
0 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
968000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
208000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-190000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-130000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-114000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-65000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-161000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-455000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1213000 | usd |
| CY2024Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10869000 | usd |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7891000 | usd |
| CY2024Q2 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
42000 | usd |
| CY2023Q2 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
0 | usd |
| CY2024Q2 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
5425000 | usd |
| CY2023Q2 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
0 | usd |
| CY2024Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5467000 | usd |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
| CY2024Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
| CY2023Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1072000 | usd |
| CY2024Q2 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
88000 | usd |
| CY2023Q2 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
4000 | usd |
| CY2024Q2 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | usd |
| CY2023Q2 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
201000 | usd |
| CY2024Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
88000 | usd |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
875000 | usd |
| CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-16248000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-7016000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
119166000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
16638000 | usd |
| CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
102918000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
9622000 | usd |
| CY2024Q2 | vtgn |
Insurance Premiums Settled By Issuing Note Payable
InsurancePremiumsSettledByIssuingNotePayable
|
0 | usd |
| CY2023Q2 | vtgn |
Insurance Premiums Settled By Issuing Note Payable
InsurancePremiumsSettledByIssuingNotePayable
|
880000 | usd |
| CY2024Q2 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
75000 | usd |
| CY2023Q2 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
0 | usd |
| CY2024Q2 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include, but are not limited to, those relating to stock-based compensation, revenue recognition, research and development expenses, determination of right-of-use assets under lease transactions and related lease obligations, and the assumptions used to value warrants. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may materially differ from these estimates and assumptions.</span></div> | |
| CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-366900000 | usd |
| CY2024Q2 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
108400000 | usd |
| CY2024Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
108364000 | usd |
| CY2024Q1 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
119166000 | usd |
| CY2024Q2 | vtgn |
Debt Securities Available For Sale And Cash And Cash Equivalents Amortized Cost
DebtSecuritiesAvailableForSaleAndCashAndCashEquivalentsAmortizedCost
|
13396000 | usd |
| CY2024Q2 | vtgn |
Debt Securities Available For Sale And Cash And Cash Equivalents Accumulated Gross Unrealized Gain
DebtSecuritiesAvailableForSaleAndCashAndCashEquivalentsAccumulatedGrossUnrealizedGain
|
2000 | usd |
| CY2024Q2 | vtgn |
Debt Securities Available For Sale And Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAvailableForSaleAndCashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
|
0 | usd |
| CY2024Q2 | vtgn |
Debt Securities Available For Sale And Cash And Cash Equivalents
DebtSecuritiesAvailableForSaleAndCashAndCashEquivalents
|
13398000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
0 | usd |
| CY2023Q4 | vtgn |
Warrants Exercisable Percentage Of Common Shares Outstanding Minimum Benchmark
WarrantsExercisablePercentageOfCommonSharesOutstandingMinimumBenchmark
|
0.0999 | |
| CY2023Q4 | vtgn |
Warrants Exercisable Percentage Of Common Shares Outstanding Maximum Benchmark
WarrantsExercisablePercentageOfCommonSharesOutstandingMaximumBenchmark
|
0.1999 | |
| CY2023Q4 | vtgn |
Warrant Percentage Increase Or Decrease Notice Period
WarrantPercentageIncreaseOrDecreaseNoticePeriod
|
P61D | |
| CY2024Q2 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P60D | |
| CY2024Q2 | vtgn |
Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
|
6.24 | |
| CY2024Q2 | vtgn |
Class Of Warrant Or Right Outstanding Warrants Subject To Anti Dilution Protection Feature
ClassOfWarrantOrRightOutstandingWarrantsSubjectToAntiDilutionProtectionFeature
|
0 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
815357 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
33.07 | |
| CY2024 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y8M12D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
165000 | usd |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2073750 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.69 | |
| CY2024Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
9582 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
32.46 | |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2879525 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
11.91 | |
| CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y | |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
422000 | usd |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
765495 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
32.85 | |
| CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y4M24D | |
| CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | usd |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
2879525 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
11.91 | |
| CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P9Y | |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
422000 | usd |
| CY2024Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1160000 | usd |
| CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
569000 | usd |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.55 | |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.21 | |
| CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1000000.0 | usd |
| CY2023Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
400000 | usd |
| CY2023Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2024Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2024Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
8200000 | usd |
| CY2024Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
23484319 | shares |
| CY2023Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
758241 | shares |
| CY2024Q2 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
100000 | usd |
| CY2023Q2 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
200000 | usd |
| CY2024Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
| CY2024Q2 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
| CY2024Q2 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
| CY2024Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |
